Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.
作者信息
Terpos Evangelos, Trougakos Ioannis P, Apostolakou Filia, Charitaki Ioanna, Sklirou Aimilia D, Mavrianou Nefeli, Papanagnou Eleni-Dimitra, Liacos Christine-Ivy, Gumeni Sentiljana, Rentziou Gianna, Korompoki Eleni, Papassotiriou Ioannis, Dimopoulos Meletios A
机构信息
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
出版信息
Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24.
Abstract
摘要
相似文献
1
Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.
Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24.
2
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.
J Intern Med. 2021 Dec;290(6):1272-1274. doi: 10.1111/joim.13366. Epub 2021 Aug 2.
3
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
EBioMedicine. 2021 Aug;70:103523. doi: 10.1016/j.ebiom.2021.103523. Epub 2021 Aug 12.
4
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
5
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.
Nat Med. 2021 Jun;27(6):981-984. doi: 10.1038/s41591-021-01325-6. Epub 2021 Apr 1.
6
Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine.
JAMA Netw Open. 2021 Sep 1;4(9):e2124331. doi: 10.1001/jamanetworkopen.2021.24331.
7
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2.
8
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
N Engl J Med. 2021 Jul 1;385(1):90-92. doi: 10.1056/NEJMc2103825. Epub 2021 Apr 14.
9
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
Blood. 2021 Jul 1;137(26):3674-3676. doi: 10.1182/blood.2021011904.
10
Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
JAMA. 2021 Apr 13;325(14):1467-1469. doi: 10.1001/jama.2021.3341.
引用本文的文献
1
Anti-SARS-CoV-2 Antibody Levels in a Cohort of Health Care Workers Before and After the Omicron Wave in Canada.
J Assoc Med Microbiol Infect Dis Can. 2025 May 29;10(2):127-145. doi: 10.3138/jammi-2024-0029. eCollection 2025 Jun.
2
Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population.
Vaccines (Basel). 2025 Jan 13;13(1):67. doi: 10.3390/vaccines13010067.
3
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies.
Vaccines (Basel). 2025 Jan 12;13(1):61. doi: 10.3390/vaccines13010061.
4
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19.
Nat Aging. 2024 Aug;4(8):1121-1136. doi: 10.1038/s43587-024-00644-w. Epub 2024 Jun 25.
5
High Concentration of Anti-SARS-CoV-2 Antibodies 2 Years after COVID-19 Vaccination Stems Not Only from Boosters but Also from Widespread, Often Unrecognized, Contact with the Virus.
Vaccines (Basel). 2024 Apr 28;12(5):471. doi: 10.3390/vaccines12050471.
6
Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination.
BMC Infect Dis. 2024 Apr 24;24(1):436. doi: 10.1186/s12879-024-09338-5.
7
SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series.
Sci Rep. 2024 Apr 18;14(1):8426. doi: 10.1038/s41598-024-58811-3.
8
A Longitudinal Study in Tunisia to Assess the Anti-RBD IgG and IgA Responses Induced by Three Different COVID-19 Vaccine Platforms.
Trop Med Infect Dis. 2024 Mar 13;9(3):61. doi: 10.3390/tropicalmed9030061.
9
A Potential Association between Abdominal Obesity and the Efficacy of Humoral Immunity Induced by COVID-19 and by the AZD1222, Convidecia, BNT162b2, Sputnik V, and CoronaVac Vaccines.
Vaccines (Basel). 2024 Jan 15;12(1):88. doi: 10.3390/vaccines12010088.
10
Robust memory humoral immune response to SARS-CoV-2 in the tonsils of adults and children.
Front Immunol. 2023 Dec 11;14:1291534. doi: 10.3389/fimmu.2023.1291534. eCollection 2023.
本文引用的文献
1
Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
JAMA. 2021 Apr 13;325(14):1467-1469. doi: 10.1001/jama.2021.3341.
2
First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
JAMA. 2021 Apr 27;325(16):1670-1671. doi: 10.1001/jama.2021.2352.
3
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.
J Biomed Sci. 2021 Jan 12;28(1):9. doi: 10.1186/s12929-020-00703-5.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.
Nat Biotechnol. 2020 Sep;38(9):1073-1078. doi: 10.1038/s41587-020-0631-z. Epub 2020 Jul 23.
6
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.
Science. 2020 Aug 21;369(6506):956-963. doi: 10.1126/science.abc7520. Epub 2020 Jun 15.
Zotero 插件